Biomarker-enhanced cardiovascular risk prediction in patients with cancer: a prospective cohort study
A recent prospective cohort study, co-directed by Florian Moik, Cihan Ay, and Fabrizio Montecucco in collaboration with the CMC, provides insights into of cardiovascular biomarkers for the prediction of major adverse cardiovascular events in cancer patients.
Florian Wenzl